CD274 and urinary bladder carcinoma: With the advent of the immunotherapy era represented by PD-1/PD-L1 inhibitors, research has shown that immunotherapy can benefit some bladder cancer patients, but it is only effective for a small number of patients, especially those with high expression of PD-L1.